Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges
- PMID: 24561654
- DOI: 10.1016/j.bbadis.2014.02.006
Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges
Abstract
Colorectal cancer, a leading cause of mortality worldwide, is a multistep disorder that results from the alteration of genetic and epigenetic mechanisms under contextual influence. Epigenetic aberrations, including DNA methylation, histone modifications, chromatin remodeling and non-coding RNAs, affect every aspect of tumor development from initiation to metastasis. Cancer stem cell promotion is also included in the wide spectrum of epigenetic dysregulations. Elucidation of this complex crosstalk network may offer new insights in the molecular interactions involved in the pathogenesis of colorectal carcinogenesis. In the era of translational medicine new horizons are opened for the pursuit of personalized therapeutic approaches and the development of novel and accurate diagnostic, prognostic and therapy-assessment markers. This review discusses the implications of epigenetic mechanisms in tumor biology and their applications "from bench to bedside".
Keywords: Colorectal cancer; DNA methylation; Epigenetics; Histone modification; Prognosis; Therapy.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
The role of epigenetics in colorectal cancer.Expert Rev Gastroenterol Hepatol. 2014 Nov;8(8):935-48. doi: 10.1586/17474124.2014.924397. Epub 2014 May 29. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24871610 Review.
-
DNA methylation and chromatin modifiers in colorectal cancer.Mol Aspects Med. 2019 Oct;69:73-92. doi: 10.1016/j.mam.2019.04.002. Epub 2019 Apr 30. Mol Aspects Med. 2019. PMID: 31028771 Review.
-
Epigenetics of colorectal cancer.Methods Mol Biol. 2015;1238:405-24. doi: 10.1007/978-1-4939-1804-1_22. Methods Mol Biol. 2015. PMID: 25421673 Review.
-
Epigenetic regulation and colorectal cancer.Dis Colon Rectum. 2012 Jan;55(1):96-104. doi: 10.1097/DCR.0b013e318233a1ef. Dis Colon Rectum. 2012. PMID: 22156874 Review.
-
Epigenetic therapy for colorectal cancer.Methods Mol Biol. 2015;1238:771-82. doi: 10.1007/978-1-4939-1804-1_40. Methods Mol Biol. 2015. PMID: 25421691 Review.
Cited by
-
Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer.Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821997829. doi: 10.1177/1533033821997829. Technol Cancer Res Treat. 2021. PMID: 33733923 Free PMC article.
-
miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.World J Gastroenterol. 2016 Jun 28;22(24):5589-97. doi: 10.3748/wjg.v22.i24.5589. World J Gastroenterol. 2016. PMID: 27350737 Free PMC article.
-
Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer.Biomedicine (Taipei). 2019 Dec;9(4):22. doi: 10.1051/bmdcn/2019090422. Epub 2019 Nov 14. Biomedicine (Taipei). 2019. PMID: 31724937 Free PMC article.
-
Modeling colorectal cancers using multidimensional organoids.Adv Cancer Res. 2021;151:345-383. doi: 10.1016/bs.acr.2021.02.005. Epub 2021 Mar 26. Adv Cancer Res. 2021. PMID: 34148617 Free PMC article. Review.
-
Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway.J Immunol Res. 2022 Apr 20;2022:4012920. doi: 10.1155/2022/4012920. eCollection 2022. J Immunol Res. 2022. PMID: 35497876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical